Expression of interleukin-4 and interferon-gamma in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy
- PMID: 10548367
- DOI: 10.1023/a:1026699108147
Expression of interleukin-4 and interferon-gamma in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy
Abstract
Although possessing a morphologically similar small bowel abnormality to patients with isolated gluten-sensitive enteropathy (GSE), patients with dermatitis herpetiformis (DH) have few gastrointestinal symptoms and exhibit blistering skin lesions and cutaneous IgA deposits. To determine whether clinical discrepancies between these gluten-sensitive conditions might be the result of different patterns of small bowel cytokine expression, duodenal biopsies were obtained from eight DH patients and nine isolated GSE patients. Biopsies were evaluated for interleukin-4 (IL-4) and interferon-gamma (IFN-gamma) expression by reverse-transcriptase polymerase chain reaction (message) and immunohistochemistry (protein). In DH patients, most of whom had no gut symptoms, IFN-gamma mRNA expression was significantly less than in isolated GSE patients with symptomatic gut disease. Conversely, IL-4 mRNA expression in DH patients was greater than that found among isolated GSE patients. These findings suggest that the different clinical phenotypes of gluten sensitivity may be caused by variation in cytokine expression in the small bowel response to gluten.
Similar articles
-
Increased production of IL-4 by gut T-cell lines from patients with dermatitis herpetiformis compared to patients with isolated gluten-sensitive enteropathy.Dig Dis Sci. 2000 Oct;45(10):2036-43. doi: 10.1023/a:1005512513007. Dig Dis Sci. 2000. PMID: 11117580
-
TCR Vbeta expression in the small bowel of patients with dermatitis herpetiformis and gluten sensitive enteropathy. Limited expression in dermatitis herpetiformis and treated asymptomatic gluten sensitive enteropathy.Exp Dermatol. 2000 Aug;9(4):275-82. doi: 10.1034/j.1600-0625.2000.009004275.x. Exp Dermatol. 2000. PMID: 10949550
-
Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.Ann Med. 2017 Feb;49(1):23-31. doi: 10.1080/07853890.2016.1222450. Epub 2016 Dec 14. Ann Med. 2017. PMID: 27499257 Review.
-
Characterization of circulating and cutaneous IgA immune complexes in patients with dermatitis herpetiformis.J Immunol. 1985 Sep;135(3):1760-5. J Immunol. 1985. PMID: 4020133
-
Dermatitis herpetiformis.Clin Dermatol. 2012 Jan-Feb;30(1):56-9. doi: 10.1016/j.clindermatol.2011.03.010. Clin Dermatol. 2012. PMID: 22137227 Review.
Cited by
-
A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.J Clin Invest. 2004 Oct;114(8):1090-7. doi: 10.1172/JCI21055. J Clin Invest. 2004. PMID: 15489956 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous